Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)
47.53
-0.47 (-0.98%)
Sep 8, 2025, 3:00 PM CST
SHA:688180 Revenue
Shanghai Junshi Biosciences had revenue of 667.79M CNY in the quarter ending June 30, 2025, with 64.78% growth. This brings the company's revenue in the last twelve months to 2.33B, up 43.96% year-over-year. In the year 2024, Shanghai Junshi Biosciences had annual revenue of 1.95B with 29.67% growth.
Revenue (ttm)
2.33B
Revenue Growth
+43.96%
P/S Ratio
19.29
Revenue / Employee
904.05K
Employees
2,578
Market Cap
44.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.95B | 445.77M | 29.67% |
Dec 31, 2023 | 1.50B | 49.06M | 3.38% |
Dec 31, 2022 | 1.45B | -2.57B | -63.89% |
Dec 31, 2021 | 4.02B | 2.43B | 152.36% |
Dec 31, 2020 | 1.59B | 819.81M | 105.77% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Shanghai United Imaging Healthcare | 10.98B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |